TCGA data from Kaplan–Meier survival analysis suggested that high MXD3 expression indicates a poor prognosis for patients suffering from ACC, LIHC, KIRC, LGG, MESO, and KIRP. This evidence concerns the gene MXD3 and adrenal cortex carcinoma.